Cardiome Closes Public Offering of 11,500,000 Common Shares

NASDAQ: CRME TSX: COM VANCOUVER, July 29, 2016 /PRNewswire/ Cardiome Pharma Corp. ( Cardiome or the Company ) (NASDAQ: CRME / TSX: COM) announced today that it has closed its previously announced underwritten public offering (the Offering ) of 11,500,000 common shares from treasury, including the underwriters full exercise of their option to purchase 1,500,000 additional shares, at a price to the public of US$3.00 per common share, for aggregate gross proceeds to the Company of US$34,500,000, before deducting the underwriting commission


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: